1581b. Antimicrobial Susceptibility Testing of Urine Isolates from Veterans to Guide Empiric Therapy of Suspected Urinary Tract Infection (UTI)
Session: Poster Abstract Session: Clinical Infectious Diseases: UTIs
Saturday, October 10, 2015
Room: Poster Hall
  • Urine Antibiogram ID week poster 2015 FINAL as submitted.pdf (191.9 kB)
  • Background:

    UTI is common among patients at Veterans Affairs Medical Centers (VAMCs), many of whom are elderly men with underlying medical or urological problems. Most UTI treatment guidelines address uncomplicated UTI in women and presume knowledge of local uropathogen susceptibility patterns, which often are unknown or are inferred from E. coli. To inform selection of empiric therapy for UTI at our VAMC, we compiled susceptibility data for one year's urine isolates.


    Susceptibility results (from a bioMerieux VITEK® instrument) were compiled for the 2,109 significant urine isolates in the Minneapolis VAMC clinical microbiology laboratory from June 1, 2013 to May 31, 2014. For "drug-bug" combinations that were not tested directly we imputed results based on local or published data, and/or expert opinion (40% of 52,725 data points). Cumulative % susceptible was then calculated for 25 relevant agents, both overall and stratified by Gram stain group. Given the uncertainty, susceptibility of Enterococcus spp. (ENTC) to trimethoprim/sulfamethoxazole (SXT) was analyzed as both 0% and 100%.


    Of 2,109 urine isolates, 561 were Gram-positive and 1,548 Gram-negative. E. coli predominated (32%), followed by ENTC (18%), Klebsiella (15%), Staphylococcus (9%), and Pseudomonas (8%). The most active oral agents (as % susceptible) were SXT (79%, if ENTC susceptible; 60%, if resistant), fluoroquinolones (FQs, 68%), and nitrofurantoin (NF, 64%). The most active intravenous agents were imipenem (93%), piperacillin/tazobactam (91%), aminoglycosides (77-81%), cefepime (74%), ertapenem (69%), and 3rd-gen. cephalosporins (65-69%). Antibiotic rank order by % susceptible differed greatly for Gram-positives vs. -negatives, and for E. coli vs. other Gram-negatives (not shown).


    Among urine isolates from veterans, no oral agent provided ≥ 80% overall susceptibility; SXT either led or trailed FQs and NF, depending on its presumed activity against ENTC; and FQs and NF were closely matched. E. coli was a minor contributor and represented poorly the total population. Data such as these could improve selection of empirical UTI therapy for veterans, as could urine Gram stains.

    Ketzela J. Marsh, MD1, John Holter, MT (ASCP)2, Lesley Mundy, MT (ASCP)2 and James R. Johnson, MD, FIDSA, FACP, FRCPE1,3, (1)Department of Medicine, Division of Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN, (2)Clinical Microbiology Laboratory, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, (3)Infectious Diseases, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN


    K. J. Marsh, None

    J. Holter, None

    L. Mundy, None

    J. R. Johnson, Crucell: Consultant , Consulting fee
    ICET: Consultant , Consulting fee
    Merk: Investigator , Grant recipient
    Tetraphase: Investigator , Grant recipient

    << Previous Abstract | Next Abstract

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.